<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">37993433</PMID><DateCompleted><Year>2023</Year><Month>11</Month><Day>24</Day></DateCompleted><DateRevised><Year>2024</Year><Month>06</Month><Day>10</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">2041-1723</ISSN><JournalIssue CitedMedium="Internet"><Volume>14</Volume><Issue>1</Issue><PubDate><Year>2023</Year><Month>Nov</Month><Day>22</Day></PubDate></JournalIssue><Title>Nature communications</Title><ISOAbbreviation>Nat Commun</ISOAbbreviation></Journal><ArticleTitle>Distinct transcriptomic profiles in children prior to the appearance of type 1 diabetes-linked islet autoantibodies and following enterovirus infection.</ArticleTitle><Pagination><StartPage>7630</StartPage><MedlinePgn>7630</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">7630</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1038/s41467-023-42763-9</ELocationID><Abstract><AbstractText>Although the genetic basis and pathogenesis of type 1 diabetes have been studied extensively, how host responses to environmental factors might contribute to autoantibody development remains largely unknown. Here, we use longitudinal blood transcriptome sequencing data to characterize host responses in children within 12 months prior to the appearance of type 1 diabetes-linked islet autoantibodies, as well as matched control children. We report that children who present with insulin-specific autoantibodies first have distinct transcriptional profiles from those who develop GADA autoantibodies first. In particular, gene dosage-driven expression of GSTM1 is associated with GADA autoantibody positivity. Moreover, compared with controls, we observe increased monocyte and decreased B cell proportions 9-12 months prior to autoantibody positivity, especially in children who developed antibodies against insulin first. Lastly, we show that control children present transcriptional signatures consistent with robust immune responses to enterovirus infection, whereas children who later developed islet autoimmunity do not. These findings highlight distinct immune-related transcriptomic differences between case and control children prior to case progression to islet autoimmunity and uncover deficient antiviral response in children who later develop islet autoimmunity.</AbstractText><CopyrightInformation>© 2023. The Author(s).</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y" EqualContrib="Y"><LastName>Lin</LastName><ForeName>Jake</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Prostate Cancer Research Center, Faculty of Medicine and Health Technology, Tampere University and Tays Cancer Centre, Tampere, Finland.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Biostatistics, Health Sciences, Faculty of Social Sciences, Tampere University, Tampere, Finland.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Finnish Institute of Molecular Medicine, FIMM, University of Helsinki, 00290, Helsinki, Finland.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Medical Epidemiology and Biostatistics, Karolinska Institute, Stockholm, Sweden.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y" EqualContrib="Y"><LastName>Moradi</LastName><ForeName>Elaheh</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Prostate Cancer Research Center, Faculty of Medicine and Health Technology, Tampere University and Tays Cancer Centre, Tampere, Finland.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>A.I. Virtanen Institute for Molecular Sciences, University of Eastern Finland, Kuopio, 70150, Finland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y" EqualContrib="Y"><LastName>Salenius</LastName><ForeName>Karoliina</ForeName><Initials>K</Initials><Identifier Source="ORCID">0000-0003-1104-0406</Identifier><AffiliationInfo><Affiliation>Prostate Cancer Research Center, Faculty of Medicine and Health Technology, Tampere University and Tays Cancer Centre, Tampere, Finland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lehtipuro</LastName><ForeName>Suvi</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Prostate Cancer Research Center, Faculty of Medicine and Health Technology, Tampere University and Tays Cancer Centre, Tampere, Finland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Häkkinen</LastName><ForeName>Tomi</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Prostate Cancer Research Center, Faculty of Medicine and Health Technology, Tampere University and Tays Cancer Centre, Tampere, Finland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Laiho</LastName><ForeName>Jutta E</ForeName><Initials>JE</Initials><AffiliationInfo><Affiliation>Department of Virology, Faculty of Medicine and Health Technology, Tampere University, Tampere, Finland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Oikarinen</LastName><ForeName>Sami</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Virology, Faculty of Medicine and Health Technology, Tampere University, Tampere, Finland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Randelin</LastName><ForeName>Sofia</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Prostate Cancer Research Center, Faculty of Medicine and Health Technology, Tampere University and Tays Cancer Centre, Tampere, Finland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Parikh</LastName><ForeName>Hemang M</ForeName><Initials>HM</Initials><Identifier Source="ORCID">0000-0002-9076-6709</Identifier><AffiliationInfo><Affiliation>Health Informatics Institute, Morsani College of Medicine, University of South Florida, Tampa, FL, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Krischer</LastName><ForeName>Jeffrey P</ForeName><Initials>JP</Initials><AffiliationInfo><Affiliation>Health Informatics Institute, Morsani College of Medicine, University of South Florida, Tampa, FL, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Toppari</LastName><ForeName>Jorma</ForeName><Initials>J</Initials><Identifier Source="ORCID">0000-0003-2228-334X</Identifier><AffiliationInfo><Affiliation>Research Centre for Integrative Physiology and Pharmacology, Institute of Biomedicine, and Centre for Population Health Research, University of Turku, Turku, Finland.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Pediatrics, Turku University Hospital, Turku, Finland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lernmark</LastName><ForeName>Åke</ForeName><Initials>Å</Initials><Identifier Source="ORCID">0000-0003-1735-0499</Identifier><AffiliationInfo><Affiliation>Department of Clinical Sciences, Lund University CRC, Skåne University Hospital, Malmö, Sweden.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Petrosino</LastName><ForeName>Joseph F</ForeName><Initials>JF</Initials><AffiliationInfo><Affiliation>Alkek Center for Metagenomics and Microbiome Research, Department of Molecular Virology and Microbiology, Baylor College of Medicine, Houston, TX, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ajami</LastName><ForeName>Nadim J</ForeName><Initials>NJ</Initials><Identifier Source="ORCID">0000-0002-3808-8576</Identifier><AffiliationInfo><Affiliation>Alkek Center for Metagenomics and Microbiome Research, Department of Molecular Virology and Microbiology, Baylor College of Medicine, Houston, TX, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Platform for Innovative Microbiome &amp; Translational Research (PRIME-TR), Moon Shots™ Program, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>She</LastName><ForeName>Jin-Xiong</ForeName><Initials>JX</Initials><AffiliationInfo><Affiliation>Jinfiniti Precision Medicine, Inc., Augusta, GA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hagopian</LastName><ForeName>William A</ForeName><Initials>WA</Initials><Identifier Source="ORCID">0000-0003-2979-0475</Identifier><AffiliationInfo><Affiliation>Pacific Northwest Research Institute, Seattle, WA, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Medicine, University of Washington, Seattle, WA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rewers</LastName><ForeName>Marian J</ForeName><Initials>MJ</Initials><Identifier Source="ORCID">0000-0003-3829-9207</Identifier><AffiliationInfo><Affiliation>Barbara Davis Center for Childhood Diabetes, University of Colorado, Aurora, CO, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lloyd</LastName><ForeName>Richard E</ForeName><Initials>RE</Initials><AffiliationInfo><Affiliation>Alkek Center for Metagenomics and Microbiome Research, Department of Molecular Virology and Microbiology, Baylor College of Medicine, Houston, TX, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rautajoki</LastName><ForeName>Kirsi J</ForeName><Initials>KJ</Initials><Identifier Source="ORCID">0000-0001-6549-7810</Identifier><AffiliationInfo><Affiliation>Prostate Cancer Research Center, Faculty of Medicine and Health Technology, Tampere University and Tays Cancer Centre, Tampere, Finland. kirsi.rautajoki@tuni.fi.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hyöty</LastName><ForeName>Heikki</ForeName><Initials>H</Initials><Identifier Source="ORCID">0000-0003-0370-4145</Identifier><AffiliationInfo><Affiliation>Department of Virology, Faculty of Medicine and Health Technology, Tampere University, Tampere, Finland. heikki.hyoty@tuni.fi.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Fimlab Laboratories, Tampere, Finland. heikki.hyoty@tuni.fi.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Nykter</LastName><ForeName>Matti</ForeName><Initials>M</Initials><Identifier Source="ORCID">0000-0001-6956-2843</Identifier><AffiliationInfo><Affiliation>Prostate Cancer Research Center, Faculty of Medicine and Health Technology, Tampere University and Tays Cancer Centre, Tampere, Finland. matti.nykter@tuni.fi.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Foundation for the Finnish Cancer Institute, Helsinki, Finland. matti.nykter@tuni.fi.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><CollectiveName>TEDDY Study Group</CollectiveName></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>U01 DK063821</GrantID><Acronym>DK</Acronym><Agency>NIDDK NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>UC4 DK063863</GrantID><Acronym>DK</Acronym><Agency>NIDDK NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>UL1 TR002535</GrantID><Acronym>TR</Acronym><Agency>NCATS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>U01 DK128847</GrantID><Acronym>DK</Acronym><Agency>NIDDK NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>U01 DK063790</GrantID><Acronym>DK</Acronym><Agency>NIDDK NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>UL1 TR000064</GrantID><Acronym>TR</Acronym><Agency>NCATS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>HHSN267200700014C</GrantID><Acronym>LM</Acronym><Agency>NLM NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>U01 DK063836</GrantID><Acronym>DK</Acronym><Agency>NIDDK NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>U01 DK063829</GrantID><Acronym>DK</Acronym><Agency>NIDDK NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>U01 DK063865</GrantID><Acronym>DK</Acronym><Agency>NIDDK NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>UC4 DK095300</GrantID><Acronym>DK</Acronym><Agency>NIDDK NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>UC4 DK063861</GrantID><Acronym>DK</Acronym><Agency>NIDDK NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>UC4 DK063829</GrantID><Acronym>DK</Acronym><Agency>NIDDK NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>UC4 DK063821</GrantID><Acronym>DK</Acronym><Agency>NIDDK NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>UC4 DK117483</GrantID><Acronym>DK</Acronym><Agency>NIDDK NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>UC4 DK063836</GrantID><Acronym>DK</Acronym><Agency>NIDDK NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>UC4 DK112243</GrantID><Acronym>DK</Acronym><Agency>NIDDK NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>U01 DK124166</GrantID><Acronym>DK</Acronym><Agency>NIDDK NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>U01 DK063861</GrantID><Acronym>DK</Acronym><Agency>NIDDK NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>UC4 DK063865</GrantID><Acronym>DK</Acronym><Agency>NIDDK NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>U01 DK063863</GrantID><Acronym>DK</Acronym><Agency>NIDDK NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>UC4 DK106955</GrantID><Acronym>DK</Acronym><Agency>NIDDK NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>UC4 DK100238</GrantID><Acronym>DK</Acronym><Agency>NIDDK NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>11</Month><Day>22</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Nat Commun</MedlineTA><NlmUniqueID>101528555</NlmUniqueID><ISSNLinking>2041-1723</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D001323">Autoantibodies</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D007328">Insulin</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002648" MajorTopicYN="N">Child</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001323" MajorTopicYN="N">Autoantibodies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D003922" MajorTopicYN="Y">Diabetes Mellitus, Type 1</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D059467" MajorTopicYN="N">Transcriptome</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015551" MajorTopicYN="N">Autoimmunity</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D007328" MajorTopicYN="N">Insulin</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004769" MajorTopicYN="Y">Enterovirus Infections</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D007515" MajorTopicYN="Y">Islets of Langerhans</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading></MeshHeadingList><CoiStatement>H.H. is a shareholder and chairman of the board of Vactech, and a member of the Scientific Advisory Board of Provention Bio, which develops vaccines against picornaviruses and CVB. The remaining authors declare no competing interests.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2023</Year><Month>2</Month><Day>1</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2023</Year><Month>10</Month><Day>17</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>11</Month><Day>24</Day><Hour>6</Hour><Minute>43</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>11</Month><Day>23</Day><Hour>0</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>11</Month><Day>22</Day><Hour>23</Hour><Minute>16</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2023</Year><Month>11</Month><Day>22</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">37993433</ArticleId><ArticleId IdType="pmc">PMC10665402</ArticleId><ArticleId IdType="doi">10.1038/s41467-023-42763-9</ArticleId><ArticleId IdType="pii">10.1038/s41467-023-42763-9</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Bottazzo GF, Florin-Christensen A, Doniach D. Islet-cell antibodies in diabetes mellitus with autoimmune polyendocrine deficiencies. Lancet. 1974;2:1279–1283. doi: 10.1016/S0140-6736(74)90140-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(74)90140-8</ArticleId><ArticleId IdType="pubmed">4139522</ArticleId></ArticleIdList></Reference><Reference><Citation>MacCuish AC, Irvine WJ, Barnes EW, Duncan LJ. Antibodies to pancreatic islet cells in insulin-dependent diabetics with coexistent autoimmune disease. Lancet. 1974;2:1529–1531. doi: 10.1016/S0140-6736(74)90281-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(74)90281-5</ArticleId><ArticleId IdType="pubmed">4140978</ArticleId></ArticleIdList></Reference><Reference><Citation>Knip M. Type 1 diabetes mellitus is a heterogeneous disease. Nat. Rev. Endocrinol. 2017;13:1. doi: 10.1038/nrendo.2017.84.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nrendo.2017.84</ArticleId><ArticleId IdType="pubmed">28685767</ArticleId></ArticleIdList></Reference><Reference><Citation>Battaglia M, et al. Introducing the endotype concept to address the challenge of disease heterogeneity in type 1 diabetes. Diabetes Care. 2020;43:5–12. doi: 10.2337/dc19-0880.</Citation><ArticleIdList><ArticleId IdType="doi">10.2337/dc19-0880</ArticleId><ArticleId IdType="pmc">PMC6925574</ArticleId><ArticleId IdType="pubmed">31753960</ArticleId></ArticleIdList></Reference><Reference><Citation>Maitra, K. &amp; Abbas, A. K. The endocrine system. In Robbins and Cotran Pathologic basis of disease 7th edn, (eds Gruliow, R. &amp; Schmitt, W.) 1155–1226 (Elsevier, Philadelphia, 2005).</Citation></Reference><Reference><Citation>Singh S, et al. Prevalence of autoantibodies and HLA DR, DQ in type 1 diabetes mellitus. J. Clin. Diagn. Res. 2016;10:EC09–EC13.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5020266</ArticleId><ArticleId IdType="pubmed">27630850</ArticleId></ArticleIdList></Reference><Reference><Citation>Krischer JP, et al. Genetic and environmental interactions modify the risk of diabetes-related autoimmunity by 6 years of age: the TEDDY study. Diabetes Care. 2017;40:1194–1202. doi: 10.2337/dc17-0238.</Citation><ArticleIdList><ArticleId IdType="doi">10.2337/dc17-0238</ArticleId><ArticleId IdType="pmc">PMC5566280</ArticleId><ArticleId IdType="pubmed">28646072</ArticleId></ArticleIdList></Reference><Reference><Citation>Törn C, et al. Role of type 1 diabetes–associated snps on risk of autoantibody positivity in the TEDDY study. Diabetes. 2015;64:1818–1829. doi: 10.2337/db14-1497.</Citation><ArticleIdList><ArticleId IdType="doi">10.2337/db14-1497</ArticleId><ArticleId IdType="pmc">PMC4407865</ArticleId><ArticleId IdType="pubmed">25422107</ArticleId></ArticleIdList></Reference><Reference><Citation>Krischer JP, et al. Predicting islet cell autoimmunity and type 1 diabetes: an 8-year TEDDY study progress report. Diabetes Care. 2019;42:1051–1060. doi: 10.2337/dc18-2282.</Citation><ArticleIdList><ArticleId IdType="doi">10.2337/dc18-2282</ArticleId><ArticleId IdType="pmc">PMC6609953</ArticleId><ArticleId IdType="pubmed">30967432</ArticleId></ArticleIdList></Reference><Reference><Citation>Nelson AJ, et al. Lipid mediators and biomarkers associated with type 1 diabetes development. JCI Insight. 2020;5:e138034. doi: 10.1172/jci.insight.138034.</Citation><ArticleIdList><ArticleId IdType="doi">10.1172/jci.insight.138034</ArticleId><ArticleId IdType="pmc">PMC7455134</ArticleId><ArticleId IdType="pubmed">32814707</ArticleId></ArticleIdList></Reference><Reference><Citation>Balzano-Nogueira L, et al. Integrative analyses of TEDDY Omics data reveal lipid metabolism abnormalities, increased intracellular ROS and heightened inflammation prior to autoimmunity for type 1 diabetes. Genome Biol. 2021;22:39. doi: 10.1186/s13059-021-02262-w.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13059-021-02262-w</ArticleId><ArticleId IdType="pmc">PMC7818777</ArticleId><ArticleId IdType="pubmed">33478573</ArticleId></ArticleIdList></Reference><Reference><Citation>Waugh K, et al. Increased inflammation is associated with islet autoimmunity and type 1 diabetes in the Diabetes Autoimmunity Study in the Young (DAISY) PLoS One. 2017;12:e0174840. doi: 10.1371/journal.pone.0174840.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0174840</ArticleId><ArticleId IdType="pmc">PMC5381877</ArticleId><ArticleId IdType="pubmed">28380011</ArticleId></ArticleIdList></Reference><Reference><Citation>Hagopian, W. A. &amp; Lernmark, K. Islet cell autoantibodies. In Autoantibodies (eds Peter, J. B. &amp; Shoenfeld, Y.) 441–448 (Elsevier Amsterdam, 1996).</Citation></Reference><Reference><Citation>Pihoker C, Gilliam LK, Hampe CS, Lernmark A. Autoantibodies in diabetes. Diabetes. 2005;54:S52–S61. doi: 10.2337/diabetes.54.suppl_2.S52.</Citation><ArticleIdList><ArticleId IdType="doi">10.2337/diabetes.54.suppl_2.S52</ArticleId><ArticleId IdType="pubmed">16306341</ArticleId></ArticleIdList></Reference><Reference><Citation>Ilonen J, et al. Patterns of β-cell autoantibody appearance and genetic associations during the first years of life. Diabetes. 2013;62:3636–3640. doi: 10.2337/db13-0300.</Citation><ArticleIdList><ArticleId IdType="doi">10.2337/db13-0300</ArticleId><ArticleId IdType="pmc">PMC3781470</ArticleId><ArticleId IdType="pubmed">23835325</ArticleId></ArticleIdList></Reference><Reference><Citation>Sioofy-Khojine A-B, et al. Coxsackievirus B1 infections are associated with the initiation of insulin-driven autoimmunity that progresses to type 1 diabetes. Diabetologia. 2018;61:1193–1202. doi: 10.1007/s00125-018-4561-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00125-018-4561-y</ArticleId><ArticleId IdType="pubmed">29404673</ArticleId></ArticleIdList></Reference><Reference><Citation>TEDDY Study Group. The Environmental Determinants of Diabetes in the Young (TEDDY) study: study design. Pediatr. Diabetes. 2007;8:286–298. doi: 10.1111/j.1399-5448.2007.00269.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1399-5448.2007.00269.x</ArticleId><ArticleId IdType="pubmed">17850472</ArticleId></ArticleIdList></Reference><Reference><Citation>Vehik K, et al. Prospective virome analyses in young children at increased genetic risk for type 1 diabetes. Nat. Med. 2019;25:1865–1872. doi: 10.1038/s41591-019-0667-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41591-019-0667-0</ArticleId><ArticleId IdType="pmc">PMC6898786</ArticleId><ArticleId IdType="pubmed">31792456</ArticleId></ArticleIdList></Reference><Reference><Citation>Hyöty H. Viruses in type 1 diabetes. Pediatr. Diabetes. 2016;17:56–64. doi: 10.1111/pedi.12370.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/pedi.12370</ArticleId><ArticleId IdType="pubmed">27411438</ArticleId></ArticleIdList></Reference><Reference><Citation>Arafa AA, et al. Association between pediatric adenovirus infection and type 1 diabetes. Children. 2022;9:1494. doi: 10.3390/children9101494.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/children9101494</ArticleId><ArticleId IdType="pmc">PMC9600003</ArticleId><ArticleId IdType="pubmed">36291430</ArticleId></ArticleIdList></Reference><Reference><Citation>Kallionpaa H, et al. Innate immune activity is detected prior to seroconversion in children with HLA-conferred type 1 diabetes susceptibility. Diabetes. 2014;63:2402–2414. doi: 10.2337/db13-1775.</Citation><ArticleIdList><ArticleId IdType="doi">10.2337/db13-1775</ArticleId><ArticleId IdType="pubmed">24550192</ArticleId></ArticleIdList></Reference><Reference><Citation>Ferreira RC, et al. A type I interferon transcriptional signature precedes autoimmunity in children genetically at risk for type 1 diabetes. Diabetes. 2014;63:2538–2550. doi: 10.2337/db13-1777.</Citation><ArticleIdList><ArticleId IdType="doi">10.2337/db13-1777</ArticleId><ArticleId IdType="pmc">PMC4066333</ArticleId><ArticleId IdType="pubmed">24561305</ArticleId></ArticleIdList></Reference><Reference><Citation>Lietzen N, et al. Enterovirus-associated changes in blood transcriptomic profiles of children with genetic susceptibility to type 1 diabetes. Diabetologia. 2018;61:381–388. doi: 10.1007/s00125-017-4460-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00125-017-4460-7</ArticleId><ArticleId IdType="pmc">PMC6448961</ArticleId><ArticleId IdType="pubmed">29119244</ArticleId></ArticleIdList></Reference><Reference><Citation>Xhonneux L-P, et al. Transcriptional networks in at-risk individuals identify signatures of type 1 diabetes progression. Sci. Transl. Med. 2021;13:eabd5666. doi: 10.1126/scitranslmed.abd5666.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/scitranslmed.abd5666</ArticleId><ArticleId IdType="pmc">PMC8447843</ArticleId><ArticleId IdType="pubmed">33790023</ArticleId></ArticleIdList></Reference><Reference><Citation>Haller MJ, Schatz DA. The DIPP project: 20 years of discovery in type 1 diabetes. Pediatr. Diabetes. 2016;17:5–7. doi: 10.1111/pedi.12398.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/pedi.12398</ArticleId><ArticleId IdType="pubmed">27411430</ArticleId></ArticleIdList></Reference><Reference><Citation>Onengut-Gumuscu S, et al. Fine mapping of type 1 diabetes susceptibility loci and evidence for colocalization of causal variants with lymphoid gene enhancers. Nat. Genet. 2015;47:381–386. doi: 10.1038/ng.3245.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ng.3245</ArticleId><ArticleId IdType="pmc">PMC4380767</ArticleId><ArticleId IdType="pubmed">25751624</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen EY, et al. Enrichr: interactive and collaborative HTML5 gene list enrichment analysis tool. BMC Bioinforma. 2013;14:128. doi: 10.1186/1471-2105-14-128.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1471-2105-14-128</ArticleId><ArticleId IdType="pmc">PMC3637064</ArticleId><ArticleId IdType="pubmed">23586463</ArticleId></ArticleIdList></Reference><Reference><Citation>Nakayasu ES, et al. Plasma protein biomarkers predict both the development of persistent autoantibodies and type 1 diabetes 6 months prior to the onset of autoimmunity: the TEDDY Study. Cell Rep. Med. 2023;4:101093. doi: 10.1016/j.xcrm.2023.101093.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.xcrm.2023.101093</ArticleId><ArticleId IdType="pmc">PMC10394168</ArticleId><ArticleId IdType="pubmed">37390828</ArticleId></ArticleIdList></Reference><Reference><Citation>Bogaards JJ, Venekamp JC, van Bladeren PJ. Stereoselective conjugation of prostaglandin A2 and prostaglandin J2 with glutathione, catalyzed by the human glutathione S-transferases A1-1, A2-2, M1a-1a, and P1-1. Chem. Res. Toxicol. 1997;10:310–317. doi: 10.1021/tx9601770.</Citation><ArticleIdList><ArticleId IdType="doi">10.1021/tx9601770</ArticleId><ArticleId IdType="pubmed">9084911</ArticleId></ArticleIdList></Reference><Reference><Citation>Coles BF, Kadlubar FF. Detoxification of electrophilic compounds by glutathione S-transferase catalysis: determinants of individual response to chemical carcinogens and chemotherapeutic drugs? Biofactors. 2003;17:115–130. doi: 10.1002/biof.5520170112.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/biof.5520170112</ArticleId><ArticleId IdType="pubmed">12897434</ArticleId></ArticleIdList></Reference><Reference><Citation>Hayes JD, Strange RC. Glutathione S-transferase polymorphisms and their biological consequences. Pharmacology. 2000;61:154–166. doi: 10.1159/000028396.</Citation><ArticleIdList><ArticleId IdType="doi">10.1159/000028396</ArticleId><ArticleId IdType="pubmed">10971201</ArticleId></ArticleIdList></Reference><Reference><Citation>Bekris LM, et al. Glutathione-s-transferase M1 and T1 polymorphisms and associations with type 1 diabetes age-at-onset. Autoimmunity. 2005;38:567–575. doi: 10.1080/08916930500407238.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/08916930500407238</ArticleId><ArticleId IdType="pubmed">16390810</ArticleId></ArticleIdList></Reference><Reference><Citation>Younis S, et al. The importance of the ZBED6-IGF2 axis for metabolic regulation in mouse myoblast cells. FASEB J. 2020;34:10250–10266. doi: 10.1096/fj.201901321R.</Citation><ArticleIdList><ArticleId IdType="doi">10.1096/fj.201901321R</ArticleId><ArticleId IdType="pubmed">32557799</ArticleId></ArticleIdList></Reference><Reference><Citation>Hughes A, et al. IGF2: an endocrine hormone to improve islet transplant survival. J. Endocrinol. 2014;221:R41–R48. doi: 10.1530/JOE-13-0557.</Citation><ArticleIdList><ArticleId IdType="doi">10.1530/JOE-13-0557</ArticleId><ArticleId IdType="pubmed">24883437</ArticleId></ArticleIdList></Reference><Reference><Citation>Krušinová E, Pelikánová T. Fatty acid binding proteins in adipose tissue: a promising link between metabolic syndrome and atherosclerosis? Diabetes Res. Clin. Pract. 2008;82:S127–S134. doi: 10.1016/j.diabres.2008.09.023.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.diabres.2008.09.023</ArticleId><ArticleId IdType="pubmed">18977052</ArticleId></ArticleIdList></Reference><Reference><Citation>Moore SM, Holt VV, Malpass LR, Hines IN, Wheeler MD. Fatty acid-binding protein 5 limits the anti-inflammatory response in murine macrophages. Mol. Immunol. 2015;67:265–275. doi: 10.1016/j.molimm.2015.06.001.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.molimm.2015.06.001</ArticleId><ArticleId IdType="pmc">PMC4565774</ArticleId><ArticleId IdType="pubmed">26105806</ArticleId></ArticleIdList></Reference><Reference><Citation>Bagheri R, et al. Relation of plasma fatty acid binding proteins 4 and 5 with the metabolic syndrome, inflammation and coronary calcium in patients with type-2 diabetes mellitus. Am. J. Cardiol. 2010;106:1118–1123. doi: 10.1016/j.amjcard.2010.06.028.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.amjcard.2010.06.028</ArticleId><ArticleId IdType="pmc">PMC3108486</ArticleId><ArticleId IdType="pubmed">20920650</ArticleId></ArticleIdList></Reference><Reference><Citation>Westerbacka J, et al. Genes involved in fatty acid partitioning and binding, lipolysis, monocyte/macrophage recruitment, and inflammation are overexpressed in the human fatty liver of insulin-resistant subjects. Diabetes. 2007;56:2759–2765. doi: 10.2337/db07-0156.</Citation><ArticleIdList><ArticleId IdType="doi">10.2337/db07-0156</ArticleId><ArticleId IdType="pubmed">17704301</ArticleId></ArticleIdList></Reference><Reference><Citation>Robbins CS, Swirski FK. The multiple roles of monocyte subsets in steady state and inflammation. Cell. Mol. Life Sci. 2010;67:2685–2693. doi: 10.1007/s00018-010-0375-x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00018-010-0375-x</ArticleId><ArticleId IdType="pmc">PMC11115635</ArticleId><ArticleId IdType="pubmed">20437077</ArticleId></ArticleIdList></Reference><Reference><Citation>Ingersoll MA, Platt AM, Potteaux S, Randolph GJ. Monocyte trafficking in acute and chronic inflammation. Trends Immunol. 2011;32:470–477. doi: 10.1016/j.it.2011.05.001.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.it.2011.05.001</ArticleId><ArticleId IdType="pmc">PMC3179572</ArticleId><ArticleId IdType="pubmed">21664185</ArticleId></ArticleIdList></Reference><Reference><Citation>Lin J, Kimura BY, Oikarinen S, Nykter M. Bioinformatics assembling and assessment of novel coxsackievirus B1 genome. Methods Mol. Biol. 2018;1838:261–272. doi: 10.1007/978-1-4939-8682-8_18.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/978-1-4939-8682-8_18</ArticleId><ArticleId IdType="pubmed">30129002</ArticleId></ArticleIdList></Reference><Reference><Citation>Tanaka S, et al. Enterovirus infection, CXC chemokine ligand 10 (CXCL10), and CXCR3 circuit: a mechanism of accelerated beta-cell failure in fulminant type 1 diabetes. Diabetes. 2009;58:2285–2291. doi: 10.2337/db09-0091.</Citation><ArticleIdList><ArticleId IdType="doi">10.2337/db09-0091</ArticleId><ArticleId IdType="pmc">PMC2750208</ArticleId><ArticleId IdType="pubmed">19641142</ArticleId></ArticleIdList></Reference><Reference><Citation>Roep BO, et al. Islet inflammation and CXCL10 in recent-onset type 1 diabetes. Clin. Exp. Immunol. 2010;159:338–343. doi: 10.1111/j.1365-2249.2009.04087.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1365-2249.2009.04087.x</ArticleId><ArticleId IdType="pmc">PMC2819499</ArticleId><ArticleId IdType="pubmed">20059481</ArticleId></ArticleIdList></Reference><Reference><Citation>Berg A-K, Tuvemo T, Frisk G. Enterovirus markers and serum CXCL10 in children with type 1 diabetes. J. Med. Virol. 2010;82:1594–1599. doi: 10.1002/jmv.21868.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jmv.21868</ArticleId><ArticleId IdType="pubmed">20648615</ArticleId></ArticleIdList></Reference><Reference><Citation>Zouali, M. &amp; La Cava, A. Innate Immunity Pathways in Autoimmune Diseases (Frontiers Media SA, 2019).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6557999</ArticleId><ArticleId IdType="pubmed">31214194</ArticleId></ArticleIdList></Reference><Reference><Citation>Vajjhala PR, Ve T, Bentham A, Stacey KJ, Kobe B. The molecular mechanisms of signaling by cooperative assembly formation in innate immunity pathways. Mol. Immunol. 2017;86:23–37. doi: 10.1016/j.molimm.2017.02.012.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.molimm.2017.02.012</ArticleId><ArticleId IdType="pubmed">28249680</ArticleId></ArticleIdList></Reference><Reference><Citation>Sherman BT, et al. DAVID: a web server for functional enrichment analysis and functional annotation of gene lists (2021 update) Nucleic Acids Res. 2022;50:W216–W221. doi: 10.1093/nar/gkac194.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/nar/gkac194</ArticleId><ArticleId IdType="pmc">PMC9252805</ArticleId><ArticleId IdType="pubmed">35325185</ArticleId></ArticleIdList></Reference><Reference><Citation>Drannik AG, et al. Trappin-2/elafin modulate innate immune responses of human endometrial epithelial cells to PolyI:C. PLoS One. 2012;7:e35866. doi: 10.1371/journal.pone.0035866.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0035866</ArticleId><ArticleId IdType="pmc">PMC3335805</ArticleId><ArticleId IdType="pubmed">22545145</ArticleId></ArticleIdList></Reference><Reference><Citation>Shu L, et al. Neutrophil elastase triggers the development of autoimmune diabetes by exacerbating innate immune responses in pancreatic islets of non-obese diabetic mice. Clin. Sci. 2020;134:1679–1696. doi: 10.1042/CS20200021.</Citation><ArticleIdList><ArticleId IdType="doi">10.1042/CS20200021</ArticleId><ArticleId IdType="pubmed">32633320</ArticleId></ArticleIdList></Reference><Reference><Citation>Leete P, et al. Differential insulitic profiles determine the extent of β-cell destruction and the age at onset of type 1. Diabetes Diabetes. 2016;65:1362–1369. doi: 10.2337/db15-1615.</Citation><ArticleIdList><ArticleId IdType="doi">10.2337/db15-1615</ArticleId><ArticleId IdType="pubmed">26858360</ArticleId></ArticleIdList></Reference><Reference><Citation>Leete P, et al. Studies of insulin and proinsulin in pancreas and serum support the existence of aetiopathological endotypes of type 1 diabetes associated with age at diagnosis. Diabetologia. 2020;63:1258–1267. doi: 10.1007/s00125-020-05115-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00125-020-05115-6</ArticleId><ArticleId IdType="pmc">PMC7228905</ArticleId><ArticleId IdType="pubmed">32172310</ArticleId></ArticleIdList></Reference><Reference><Citation>Beyan H, et al. Monocyte gene-expression profiles associated with childhood-onset type 1 diabetes and disease risk: a study of identical twins. Diabetes. 2010;59:1751–1755. doi: 10.2337/db09-1433.</Citation><ArticleIdList><ArticleId IdType="doi">10.2337/db09-1433</ArticleId><ArticleId IdType="pmc">PMC2889775</ArticleId><ArticleId IdType="pubmed">20393150</ArticleId></ArticleIdList></Reference><Reference><Citation>Gally F, et al. FABP5 deficiency enhances susceptibility to H1N1 influenza A virus-induced lung inflammation. Am. J. Physiol. Lung Cell. Mol. Physiol. 2013;305:L64–L72. doi: 10.1152/ajplung.00276.2012.</Citation><ArticleIdList><ArticleId IdType="doi">10.1152/ajplung.00276.2012</ArticleId><ArticleId IdType="pmc">PMC4888543</ArticleId><ArticleId IdType="pubmed">23624787</ArticleId></ArticleIdList></Reference><Reference><Citation>Pan Y, et al. Survival of tissue-resident memory T cells requires exogenous lipid uptake and metabolism. Nature. 2017;543:252–256. doi: 10.1038/nature21379.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nature21379</ArticleId><ArticleId IdType="pmc">PMC5509051</ArticleId><ArticleId IdType="pubmed">28219080</ArticleId></ArticleIdList></Reference><Reference><Citation>Klamt S, et al. Association between IgE-mediated allergies and diabetes mellitus type 1 in children and adolescents. Pediatr. Diabetes. 2015;16:493–503. doi: 10.1111/pedi.12298.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/pedi.12298</ArticleId><ArticleId IdType="pubmed">26189407</ArticleId></ArticleIdList></Reference><Reference><Citation>Bach J-F, Chatenoud L. The hygiene hypothesis: an explanation for the increased frequency of insulin-dependent diabetes. Cold Spring Harb. Perspect. Med. 2012;2:a007799. doi: 10.1101/cshperspect.a007799.</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/cshperspect.a007799</ArticleId><ArticleId IdType="pmc">PMC3281594</ArticleId><ArticleId IdType="pubmed">22355800</ArticleId></ArticleIdList></Reference><Reference><Citation>Abbas M, et al. Association of GSTM1 and GSTT1 gene polymorphisms with COVID-19 susceptibility and its outcome. J. Med. Virol. 2021;93:5446–5451. doi: 10.1002/jmv.27076.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jmv.27076</ArticleId><ArticleId IdType="pmc">PMC8242761</ArticleId><ArticleId IdType="pubmed">33990973</ArticleId></ArticleIdList></Reference><Reference><Citation>Kapahtia S, et al. Role of glutathione S transferase M1 and T1 gene polymorphism in hepatitis B related liver diseases and cryptogenic cirrhosis. J. Clin. Exp. Hepatol. 2018;8:169–172. doi: 10.1016/j.jceh.2017.05.208.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jceh.2017.05.208</ArticleId><ArticleId IdType="pmc">PMC5992258</ArticleId><ArticleId IdType="pubmed">29892180</ArticleId></ArticleIdList></Reference><Reference><Citation>Bortolli APR, Vieira VK, Stefanski EE, Lazarotto AK, Lucio LC. Relationship between GSTM1 and GSTT1 polymorphisms and HPV infection: a systematic review. Mol. Biol. Rep. 2021;48:6631–6636. doi: 10.1007/s11033-021-06515-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11033-021-06515-6</ArticleId><ArticleId IdType="pubmed">34387803</ArticleId></ArticleIdList></Reference><Reference><Citation>Ellwanger JH, Chies JAB. Host immunogenetics in tick-borne encephalitis virus infection-The CCR5 crossroad. Ticks Tick. Borne Dis. 2019;10:729–741. doi: 10.1016/j.ttbdis.2019.03.005.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ttbdis.2019.03.005</ArticleId><ArticleId IdType="pubmed">30879988</ArticleId></ArticleIdList></Reference><Reference><Citation>Ashton MP, et al. Incomplete immune response to coxsackie B viruses associates with early autoimmunity against insulin. Sci. Rep. 2016;6:32899. doi: 10.1038/srep32899.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/srep32899</ArticleId><ArticleId IdType="pmc">PMC5015062</ArticleId><ArticleId IdType="pubmed">27604323</ArticleId></ArticleIdList></Reference><Reference><Citation>Lin J, et al. Vipie: web pipeline for parallel characterization of viral populations from multiple NGS samples. BMC Genomics. 2017;18:378. doi: 10.1186/s12864-017-3721-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12864-017-3721-7</ArticleId><ArticleId IdType="pmc">PMC5430618</ArticleId><ArticleId IdType="pubmed">28506246</ArticleId></ArticleIdList></Reference><Reference><Citation>Lamichhane S, et al. Dynamics of plasma lipidome in progression to islet autoimmunity and type 1 diabetes - type 1 diabetes prediction and prevention study (DIPP) Sci. Rep. 2018;8:10635. doi: 10.1038/s41598-018-28907-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-018-28907-8</ArticleId><ArticleId IdType="pmc">PMC6045612</ArticleId><ArticleId IdType="pubmed">30006587</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee H-S, et al. Biomarker discovery study design for type 1 diabetes in The Environmental Determinants of Diabetes in the Young (TEDDY) study. Diabetes Metab. Res. Rev. 2014;30:424–434. doi: 10.1002/dmrr.2510.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/dmrr.2510</ArticleId><ArticleId IdType="pmc">PMC4058423</ArticleId><ArticleId IdType="pubmed">24339168</ArticleId></ArticleIdList></Reference><Reference><Citation>Stewart CJ, et al. Temporal development of the gut microbiome in early childhood from the TEDDY study. Nature. 2018;562:583–588. doi: 10.1038/s41586-018-0617-x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41586-018-0617-x</ArticleId><ArticleId IdType="pmc">PMC6415775</ArticleId><ArticleId IdType="pubmed">30356187</ArticleId></ArticleIdList></Reference><Reference><Citation>Dobin A, et al. STAR: ultrafast universal RNA-seq aligner. Bioinformatics. 2013;29:15–21. doi: 10.1093/bioinformatics/bts635.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/bioinformatics/bts635</ArticleId><ArticleId IdType="pmc">PMC3530905</ArticleId><ArticleId IdType="pubmed">23104886</ArticleId></ArticleIdList></Reference><Reference><Citation>Liao Y, Smyth GK, Shi W. featureCounts: an efficient general purpose program for assigning sequence reads to genomic features. Bioinformatics. 2014;30:923–930. doi: 10.1093/bioinformatics/btt656.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/bioinformatics/btt656</ArticleId><ArticleId IdType="pubmed">24227677</ArticleId></ArticleIdList></Reference><Reference><Citation>Love MI, Huber W, Anders S. Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2. Genome Biol. 2014;15:550. doi: 10.1186/s13059-014-0550-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13059-014-0550-8</ArticleId><ArticleId IdType="pmc">PMC4302049</ArticleId><ArticleId IdType="pubmed">25516281</ArticleId></ArticleIdList></Reference><Reference><Citation>Thissen D, Steinberg L, Kuang D. Quick and easy implementation of the Benjamini-Hochberg procedure for controlling the false positive rate in multiple comparisons. J. Educ. Behav. Stat. 2002;27:77–83. doi: 10.3102/10769986027001077.</Citation><ArticleIdList><ArticleId IdType="doi">10.3102/10769986027001077</ArticleId></ArticleIdList></Reference><Reference><Citation>Friedman J, Hastie T, Tibshirani R. Regularization paths for generalized linear models via coordinate descent. J. Stat. Softw. 2010;33:1–22. doi: 10.18637/jss.v033.i01.</Citation><ArticleIdList><ArticleId IdType="doi">10.18637/jss.v033.i01</ArticleId><ArticleId IdType="pmc">PMC2929880</ArticleId><ArticleId IdType="pubmed">20808728</ArticleId></ArticleIdList></Reference><Reference><Citation>Luoto S, et al. Computational characterization of suppressive immune microenvironments in glioblastoma. Cancer Res. 2018;78:5574–5585. doi: 10.1158/0008-5472.CAN-17-3714.</Citation><ArticleIdList><ArticleId IdType="doi">10.1158/0008-5472.CAN-17-3714</ArticleId><ArticleId IdType="pubmed">29921698</ArticleId></ArticleIdList></Reference><Reference><Citation>Clark K, Karsch-Mizrachi I, Lipman DJ, Ostell J, Sayers EW. GenBank. Nucleic Acids Res. 2016;44:D67–D72. doi: 10.1093/nar/gkv1276.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/nar/gkv1276</ArticleId><ArticleId IdType="pmc">PMC4702903</ArticleId><ArticleId IdType="pubmed">26590407</ArticleId></ArticleIdList></Reference><Reference><Citation>Li H, Durbin R. Fast and accurate short read alignment with Burrows–Wheeler transform. Bioinformatics. 2009;25:1754–1760. doi: 10.1093/bioinformatics/btp324.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/bioinformatics/btp324</ArticleId><ArticleId IdType="pmc">PMC2705234</ArticleId><ArticleId IdType="pubmed">19451168</ArticleId></ArticleIdList></Reference><Reference><Citation>Zerbino DR, Birney E. Velvet: algorithms for de novo short read assembly using de Bruijn graphs. Genome Res. 2008;18:821–829. doi: 10.1101/gr.074492.107.</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/gr.074492.107</ArticleId><ArticleId IdType="pmc">PMC2336801</ArticleId><ArticleId IdType="pubmed">18349386</ArticleId></ArticleIdList></Reference><Reference><Citation>Bankevich A, et al. SPAdes: a new genome assembly algorithm and its applications to single-cell sequencing. J. Comput. Biol. 2012;19:455–477. doi: 10.1089/cmb.2012.0021.</Citation><ArticleIdList><ArticleId IdType="doi">10.1089/cmb.2012.0021</ArticleId><ArticleId IdType="pmc">PMC3342519</ArticleId><ArticleId IdType="pubmed">22506599</ArticleId></ArticleIdList></Reference><Reference><Citation>Wei, T. &amp; Simko, V. R package ‘corrplot’: Visualization of a Correlation Matrix. https://github.com/taiyun/corrplot (2021).</Citation></Reference><Reference><Citation>Törn C, et al. Telomere length is not a main factor for the development of islet autoimmunity and type 1 diabetes in the TEDDY study. Sci. Rep. 2022;12:4516. doi: 10.1038/s41598-022-08058-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-022-08058-7</ArticleId><ArticleId IdType="pmc">PMC8927592</ArticleId><ArticleId IdType="pubmed">35296692</ArticleId></ArticleIdList></Reference><Reference><Citation>Taliun D, et al. Sequencing of 53,831 diverse genomes from the NHLBI TOPMed Program. Nature. 2021;590:290–299. doi: 10.1038/s41586-021-03205-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41586-021-03205-y</ArticleId><ArticleId IdType="pmc">PMC7875770</ArticleId><ArticleId IdType="pubmed">33568819</ArticleId></ArticleIdList></Reference><Reference><Citation>Jun G, Wing MK, Abecasis GR, Kang HM. An efficient and scalable analysis framework for variant extraction and refinement from population-scale DNA sequence data. Genome Res. 2015;25:918–925. doi: 10.1101/gr.176552.114.</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/gr.176552.114</ArticleId><ArticleId IdType="pmc">PMC4448687</ArticleId><ArticleId IdType="pubmed">25883319</ArticleId></ArticleIdList></Reference><Reference><Citation>Pedersen BS, Quinlan AR. Mosdepth: quick coverage calculation for genomes and exomes. Bioinformatics. 2018;34:867–868. doi: 10.1093/bioinformatics/btx699.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/bioinformatics/btx699</ArticleId><ArticleId IdType="pmc">PMC6030888</ArticleId><ArticleId IdType="pubmed">29096012</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle>